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Hyaluronidases are a family of endolytic glycoside hydrolases
that cleave the ␤1– 4 linkage between N-acetylglucosamine and
glucuronic acid in hyaluronan polymers via a substrate-assisted
mechanism. In humans, turnover of hyaluronan by this enzyme
family is critical for normal extracellular matrix remodeling.
However, elevated expression of the Hyal1 isozyme accelerates
tumor growth and metastatic progression. In this study, we used
structural information, site-directed mutagenesis, and steady
state enzyme kinetics to probe molecular determinants of
human Hyal1 function. Mutagenesis of active site residues
Glu131 and Tyr247 to Gln and Phe, respectively, eliminated activity at all hyaluronan concentrations (to 125 M or 2.5 mg/ml).
Conservative mutagenesis of Asp129 and Tyr202 significantly
impaired catalysis by increases of 5- and 10-fold in apparent Km
and reductions in Vmax of 95 and 50%, respectively. Tyr247 and
Asp129 are required for stabilization of the catalytic nucleophile,
which arises as a resonance intermediate of N-acetylglucosamine on the substrate. Glu131 is a likely proton donor for the
hydroxyl leaving group. Tyr202 is a substrate binding determinant. General disulfide reduction had no effect on activity in
solution, but enzymatic deglycosylation reduced Hyal1 activity
in a time-dependent fashion. Mutagenesis identified Asn350 glycosylation as the requisite modification. Deletion of the C-terminal epidermal growth factor-like domain, in which Asn350 is
located, also eliminated activity, irrespective of glycosylation.
Collectively, these studies define key components of Hyal1
active site catalysis, and structural factors critical for stability.
Such detailed understanding will allow rational design of
enzyme modulators.

Hyaluronidase family enzymes are broadly expressed across
many diverse species from bacteria to mammals (1, 2). Depending on the organism, there may be one or several isozymes (3).
In humans, five isozymes have been identified and characterized to varying extents for tissue and cellular distribution, activity profile, substrate specificity and function. Hyaluronidases
have been termed spreading factors because of their potential
to accelerate the spread of toxic venom effects from bees and
snakes (4). Loss of hyaluronidase expression in humans is implicated in dysregulated extracellular matrix turnover and corre-
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lates with a type of lysosomal storage disorder called mucopolysaccharidosis IX (5). Increased hyaluronidase activity may be
important for promotion of vascular development during
embryogenesis and wound healing, as well as tumor growth and
metastasis (6 –13). Because the hyaluronidase expression level
and/or activation state is thought to determine whether its
effect is to promote or suppress these processes (14), it is critical
to gain a thorough understanding of the molecular determinants of its enzymatic activity.
Human hyaluronidases are glycoside hydrolase enzymes
(Family 56 as described by the carbohydrate-active enzymes
data base at www.cazy.org (15)) characterized by substrate-assisted catalytic mechanism and retention of configuration at
the anomeric carbon subsequent to cleavage of the ␤1– 4 linkage between the N-acetylglucosamine and glucuronic acid
components of the hyaluronan (HA)2 polymer (1, 16, 17).
Members of this family are endoglycosidases, with homology to
chitinases and lysozyme (18 –21). Several of them, including
Hyal1 (22–24), exhibit an acidic activity profile, consistent with
their lysosomal function. Scheme 1 illustrates the proposed
reaction mechanism, indicating specific acidic amino acid residues directly implicated in catalysis by sequence conservation
and homology to the experimentally characterized sperm acrosomal hyaluronidase, PH-20 (25). Much of the proposed
scheme has been tested in related enzymes, the chitinases (17–
21), because no molecular characterizations of Hyal1 have been
performed. Briefly, in the resting state at its optimal pH of 4.0,
aspartate 129 and glutamate 131 essentially share a proton.
Catalysis is thought to require initiation by intramolecular resonance of the amide bond of N-acetylglucosamine in the bound
HA polymer. The transition state briefly acquires a positive
charge on the nitrogen, whereas the carbonyl becomes an oxyanion nucleophile positioned to attack the electrophilic anomeric carbon of the same N-acetylglucosamine unit. As this
intramolecular attack occurs, a five-membered ring forms,
driving out the C4 hydroxyl of the departing, newly cleaved
portion of the chain, which is protonated by Glu131. Transition
state formation is stabilized by the negative charge on Asp129
that is positioned in hydrogen bond distance to the positively
charged substrate nitrogen as Glu131 transfers its proton to the
leaving group. Glu131, thus deprotonated, serves to activate an
incoming water molecule for hydrolysis of the intramolecular
intermediate to restore N-acetylglucosamine. Support for this
mechanism derives from the observation that allosamidin, an
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The abbreviations used are: HA, hyaluronan; Hyal, hyaluronidase; DTT, dithiothreitol; PDB, protein data base; EGF, epidermal growth factor; PNGase F,
protein N-glycosidase F.
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alignments and comparisons to the bee venom hyaluronidase
structure, to identify putative active site residues and other
structural contributors. A steady state kinetic assay allowed us
to quantitatively assess the effects of site-directed mutagenesis,
disulfide reduction, and N-glycoside removal. These studies
collectively provide insights into the respective roles of these
features in Hyal1 catalysis.

SCHEME 1

oligosaccharide that terminates in a five-membered ring structure, is an effective competitive inhibitor of the closely related
chitinase family (21), which cleaves poly-N-acetylglucosamine
and shows conservation of several key active site residues,
including the aspartate and glutamate. Retention of configuration at the anomeric carbon has been shown for a related bacterial N-acetylglucosaminidase enzyme (18), and serves to support existence of an intramolecular transition state. Also
available is a crystal structure of a distantly homologous bacterial hyaluronan lyase with bound ascorbate, a potent five-membered ring-containing inhibitor of both bacterial lyases and
human hyaluronidases (24, 26).
Recently, the crystal structure for human Hyal1 was determined (27). Superposition of available crystal coordinates for a
HA tetrameric substrate bound to the bee venom hyaluronidase (4) allowed us to visualize the positions of aspartate and
glutamate in hydrogen bond distance of each other and to predict their proximity to the HA tetrasaccharide substrate. We
used this structural information, in conjunction with sequence
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EXPERIMENTAL PROCEDURES
Cell Culture, Materials, and Reagents—22Rv1 human prostate adenocarcinoma cells (28) and HEK293 human embryonic
kidney cells were purchased from ATCC and cultured as
directed by the vendor. The pFlag-CMV-3 vector, anti-FLAG
M2 antibody-conjugated resin, human umbilical cord HA,
Alcian blue, protease inhibitor mixture, bovine serum albumin,
tetramethylbenzidine, N-acetyl-D-glucosamine, and 4-(dimethylamino)benzaldehyde were purchased from Sigma.
Sodium hyaluronate (20 kDa) was from Lifecore Biomedical
Inc. (Chaska, MN). Anti-FLAG M2 antibody was purchased
from Stratagene (La Jolla, CA). Transient transfection of 22Rv1
and HEK293 cells used the FuGENE 6 transfection reagent
(Roche Diagnostics) and calcium phosphate precipitation
methods, respectively. Biotinylated HA-binding protein was
from Seikagaku (Associates of Cape Cod, East Falmouth, MA),
Streptomyces hyaluronidase was from EMD Biosciences (San
Diego, CA), protein N-glycosidase (PNGase F) was from New
England Biolabs (Ipswich, MA).
Substrate Modeling and Structure Representation—We modeled human Hyal1 in complex with bound HA tetrasaccharide
substrate by superimposing coordinates for the published Apis
melliflora hyaluronidase-HA complex (PDB accession 1FCV
(4)) onto the coordinates for human apo-Hyal1 (PDB accession
2PE4 (27)). A ribbon rendering of the model was made with
Chimera (29). To facilitate selection of residues specifically
involved in catalysis, the active site of a modeled complex with
a HA tetrasaccharide was centered upon as depicted in Fig. 1.
Side chains with potential for chemical reactivity within 5 Å of
the cleaved HA glycoside were identified, as well as several
additional residues that lined the groove possibly accommodating the full substrate. Conservation across human, bovine,
murine, and bee species in sequence alignments of all hyaluronidase isozymes was used as an additional criterion to refine our
choice of putative catalytic, substrate binding and structural
residues. Upon determining that removal of N-glycosides negatively impacted activity, we additionally identified three putative N-glycosylation sites by primary sequence analysis using
NetNGlyc (30), which are largely conserved among human hyaluronidases but not broadly across species. The side chains for
residues examined in the study were colored by atom.
Generation and Purification of Hyal1 Point Mutants—For
Hyal1 overexpression, we utilized the pFlag-CMV-3 eukaryotic
vector encoding the preprotrypsin extracellular secretion signal followed by a FLAG epitope tag fused to the coding
sequence for Hyal1 with the 21-amino acid signal peptide
removed. The preprotrypsin signal peptide ensured abundant
soluble FLAG-tagged Hyal1 secretion to the conditioned cell
culture media of transfectants. Point mutants of Hyal1 were
generated from the wild-type pFlag-Hyal1 construct using the
VOLUME 284 • NUMBER 14 • APRIL 3, 2009
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QuikChange site-directed mutagenesis kit (Stratagene) according to the manufacturer’s protocol. Primer sequences used to
create the wild-type construct and specific point mutations are
given in supplemental Table S1 (affected codons are highlighted). Coding sequences for D129N, E131Q, Y202F, N216A,
S245A, Y247F, and R265L, N350A, N350tr, and L356tr were
verified by the Genomics Core at the University of
Nebraska-Lincoln.
For initial activity measurements, recombinant plasmids
encoding N-terminal FLAG epitope fusions to Hyal1 and the
point mutants were used to transfect human 22Rv1 prostate
carcinoma cells with FuGENE 6. After 48 h in RPMI containing
1% serum, conditioned media were collected and concentrated
10-fold using Centriplus YM-10 microconcentrators. Protease
inhibitor mixture was added to the final concentrated supernatant. Soluble expression of wild-type and mutant Hyal1 was
verified by Western analysis with anti-FLAG M2 antibody.
Wild-type and mutant protein used for measurement of
kinetic constants and evaluation of post-translational modifications was purified from conditioned media of HEK293 transfectants, with the exception of the N350A, N350tr, and L356tr
mutants, which were purified from the soluble fraction of
HEK293 cell lysates. Media were harvested 48 h after calcium
phosphate transfection, concentrated at least 10-fold, and dialyzed exhaustively against 1⫻ Tris-buffered saline before applying to anti-FLAG affinity resin. After washing with 10 column
volumes of Tris-buffered saline, Hyal1-FLAG was eluted from
the column with FLAG peptide and dialyzed against hyaluronidase assay buffer (50 mM sodium formate, pH 4.0, 150 mM
NaCl). Folded structure of mutants that lacked activity was
implied by soluble secretion, but also by their intrinsic tryptophan fluorescence profiles (31), which were identical to those of
wild-type Hyal1, and red-shifted comparably upon denaturation with 3 M guanidine-HCl (supplemental Fig. S1).
Evaluation of Post-translational Modifications—To evaluate
the importance of disulfides, purified Hyal1 was incubated in
the absence or presence of 1, 10, or 50 mM DTT, or 5 mM ␤-mercaptoethanol, for 1 h at 37 °C prior to activity analysis. The
importance of N-glycosides to Hyal1 activity was examined by
enzymatic removal. Purified Hyal1 (16 g) was incubated with
10 units of PNGase F, which is specific for protein N-glycoside
digestion, in the vendor’s recommended buffer (50 mM sodium
phosphate, pH 7.5, 1% Nonidet P-40) for the indicated times
prior to Western blot and kinetic assay.
Hyaluronidase Activity Assays—Hyal1 activity was measured
by one of three methods. Substrate gel electrophoresis was performed essentially as previously described (32). Concentrated
conditioned media were electrophoresed by SDS-PAGE on a
10% polyacrylamide gel containing 0.2 mg/ml HA. After a 1-h
renaturation in 3% Triton X-100, gels were incubated in hyaluronidase assay buffer at 37 °C overnight, stained with 0.5%
Alcian blue for at least 2 h, and destained with 7% acetic acid.
Initial quantitative comparisons of wild-type and mutant
Hyal1 activity were done in an HA-coated microplate assay (13,
32–34). Briefly, serial dilutions of concentrated conditioned
media adjusted for equal Hyal1 content were applied in triplicate to 96-well plates that had been precoated overnight at 4 °C
in a solution of 50 g/ml human umbilical cord HA (200 mM
APRIL 3, 2009 • VOLUME 284 • NUMBER 14

carbonate buffer, pH 9.6), and blocked with Pierce Superblock
reagent. After a 1-h incubation in hyaluronidase assay buffer,
wells were washed and residual HA was detected by biotinylated HABP, detected with avidin-biotin horseradish peroxidase and tetramethylbenzidine substrate. Absorbance at 650
nm was used to interpolate specific activity from a concurrent
Streptomyces hyaluronidase standard curve.
Activity of wild-type and all mutant Hyal1 species was
assayed as previously described by Reissig et al. (36). Purified
enzyme (0.5 g) was incubated with increasing concentrations
of HA (20 kDa) in hyaluronidase assay buffer containing 0.1%
bovine serum albumin. The reaction was heat inactivated
(100 °C for 5 min). Cleaved ends were quantified by the Morgan-Elson color reaction (potassium tetrahydroborate and
acidified dimethylamino benzaldehyde) and absorbance at 585
nm. Molar quantity of N-acetylglucosamine reducing ends in
each sample was interpolated from a concurrently developed
standard of N-acetyl-D-glucosamine. An initial time course
revealed linear kinetics for wild-type Hyal1 from 10 to 90 min,
so a time point of 60 min was chosen for all subsequent assays.
Michaelis constants (Km and Vmax) were determined for Hyal1
species that exhibited saturable kinetics by fitting data to a
model of single site association using Prism (GraphPad Software Inc., La Jolla, CA). Heterogeneous viscosity of the HA
solutions increased above 125 M (2.5 mg/ml), so this was the
maximum concentration assayed. Thus, Km and Vmax values
were extrapolated from the curve fit where indicated.

RESULTS
Examination of the Hyal1 Active Site—Our goal in this study
was to probe the molecular interactions that specify hyaluronidase activity of human Hyal1. To obtain sufficient protein
quantities, we overexpressed the enzyme as a secreted N-terminal FLAG epitope fusion. Because a significant aspect of
research on Hyal1 is focused in the context of human cancer, we
initially used 22Rv1, a human prostate adenocarcinoma cell line
model for prostate cancer progression, as the host line for protein production. These cells normally produce little active hyaluronidase (13), and overexpression of Hyal1 was found to
accelerate their growth in culture as well as their metastatic
dissemination to lymph nodes in mouse orthotopic tumor
models (6, 37). Abundant soluble FLAG-tagged Hyal1 was
secreted to the conditioned cell culture media of transfectants.
The first round of mutagenesis was directed at characterization of the putative enzyme active site. Using crystal coordinates for the bee venom hyaluronidase complexed with HA (4),
in conjunction with human apo-Hyal1 coordinates (27), we
depicted the human enzyme bound to a tetrasaccharide substrate, and inspected the architecture of the active site (Fig. 1).
Based on this model, we identified specific residues within 5 Å
of the cleaved HA product in the active site, as likely to be
important for catalytic activity. We further selected several
amino acids that lined a groove capable of accommodating a
full-length HA polymer prior to cleavage. Accordingly, point
mutations were generated at residues Asp129, Glu131, Tyr202,
Asn216, Tyr247, Ser245, and Arg265 to investigate their individual
contributions to the enzyme mechanism. Fig. 1 illustrates the
positions of these residues in the active site of human Hyal1
JOURNAL OF BIOLOGICAL CHEMISTRY
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and residues proximal to the cleavage point of the substrate that were
likely to have been in contact with a
transition state and/or the released
portion of the cleaved HA chain,
such as Tyr202 and Tyr247. Analogy
to point mutations in both sperm
hyaluronidase, PH-20 (25), and bacterial N-acetylglucosaminidase H
(20), further suggested Asp129 and
Glu131 would be critical for catalytic
activity of the enzyme. Arg265 has
previously been predicted to be
important for substrate binding.
Asn216 is a putative N-glycosylation
site and its placement within the
substrate groove led us to test its
importance for enzyme activity
and/or substrate binding. The roles
of the serine and tyrosine residues
have not been examined in any
hyaluronidases.
Wild-type and all Hyal1 point
mutants were expressed and
secreted to conditioned media (Fig.
2A). Initial characterization of
enzyme activities was performed at
a single HA concentration in HAcoated microwell plates, using concentrated culture media from transfected tumor cells (Fig. 2B). Results
of these assays demonstrated negligible activity for the E131Q mutant
(0.11 ⫾ 0.01 units/ml of culture
media per mg of Hyal1), similar to
the vector-transfected control
media (NC, 0.07 ⫾ 0.01 units/ml/
mg). This value is 0.26 ⫾ 0.03% of
wild-type Hyal1 activity. Catalytic
function was also significantly
diminished by D129N mutagenesis
(1.4 ⫾ 0.3% of wild-type activity), as
FIGURE 1. Ribbon representation of the human Hyal1 crystal structure with bound HA tetrasaccha- well as Y202F (5.6 ⫾ 1.4%), Y247F
ride. Crystal coordinates from the HA substrate crystallized in the bee venom hyaluronidase structure (4.8 ⫾ 0.7%), and R265L (1.4 ⫾
(PDB code 1FCV) were used to place an HA tetrasaccharide in stick representation at the active site groove
of human Hyal1 (PDB code 2PE4). A, side chains of residues examined in this study for potential catalytic 0.6%). S245A retained 36 ⫾ 6% of
importance are labeled and shown in stick representations. One active site proximal disulfide is indicated normal activity, whereas N216A
(Cys207–Cys221), as well as the three asparagines that are sites for N-glycosylation (Asn99, Asn216, and
Asn350), shown modified with short carbohydrate chains as determined in the crystal structure. The molec- had no effect. The relative effects on
ular interactions occurring between bound HA and putative catalytic residues at the active site are activity were also observed when
depicted in an active site magnification (B), with hydrogen bonds indicated by thin black lines. Carbon soluble lysates from the respective
atoms of the protein residues and modifications are represented in gray, whereas those of the substrate
are in green. In both cases, nitrogen atoms are blue, oxygen are red, and sulfurs are yellow. GlcA, glucuronic transfectants were assayed in the
acid; NAG, N-acetylglucosamine.
microplate format (data not shown).
Thus, the acidic and tyrosine resirelative to HA. Substrate-proximal residues fell into three re- dues, as well as serine 245 and arginine 265, appeared to have
gions: residues still in contact with the residual tetrasaccha- prominent roles in the hyaluronidase activity of Hyal1. To
ride that can be presumed involved in binding and substrate address the specific functions of individual residues more rigrecognition; residues in non-covalent bond distance from the orously, we subsequently purified each Hyal1 species from
newly cleaved end of the substrate, including Asp129 and HEK293 transfectant media, because these cells were more easGlu131, that are obvious candidates for direct catalytic roles; ily transfected and yielded greater protein quantities.
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single site association, considering all HA substrate and product sizes equally (Table 1). Activity values for each mutant at the
50 M coating concentration used in the microplate assay were
also compared with those of the wild-type enzyme. Analysis of
E131Q kinetics revealed no significant activity at any HA concentration tested, even with 5-fold more enzyme added (Fig.
3B). This is consistent with results from the analogous PH-20
hyaluronidase mutant assayed by agarose gel electrophoresis
(25) and with the above microplate assay. Although several of
the mutants (i.e. D129N and Y202F, Fig. 3C, discussed below)
showed clear dependence of activity on substrate concentration, E131Q did not. Identical results were observed with the
Y247F mutant (Fig. 3D). Absence of activity at all substrate
concentrations indicates Glu131 and Tyr247 have critical roles in
the catalytic mechanism.
Aspartate 129 Directly Supports Catalysis, Whereas Tyrosine
202 and Serine 245 Are Substrate Binding Determinants—In
addition to Glu131, Asp129 was also predicted to be an essential
catalytic residue. Mutagenesis of this residue to the isosteric
asparagine significantly reduced Vmax and increased Km nearly
5-fold
(Fig. 3C and Table 1). Interestingly, Asp129 was not
FIGURE 2. Conservative mutagenesis of specific acidic and tyrosine residues significantly reduces Hyal1 activity. The indicated mutations were essential, because significant activity was retained. Detrimental
introduced to the wild-type pFlag-Hyal1 construct as described under “Exper- effects specifically resulting from loss of its acidic character
imental Procedures.” Conditioned media were prepared from 22Rv1 human
prostate tumor cells transfected with the respective constructs. A, equivalent suggest a direct catalytic function, whereas change in Km impliprotein amounts, as determined by Bio-Rad assay, were analyzed by Western cates Asp129 additionally in HA binding. Based on their respecblot probed with anti-FLAG antibody to compare wild-type and mutant Hyal1 tive positions, Tyr202 and Ser245 were predicted to position the
expression. B, hyaluronidase activity of the conditioned media was assayed in
a quantitative microplate assay. Densitometric measurements from the West- substrate acetamido group for attack on the anomeric carbon.
ern blot in A were used to normalize wild-type and mutant Hyal1 content. Kinetic analysis showed that Y202F reduced but did not elimiEqual amounts of the indicated Hyal1 species were serially diluted and
applied in triplicate to HA precoated microwell plates. Residual HA was quan- nate enzyme activity (Fig. 3C). However, its clear role in hydrogen bond coordination of the substrate and placement of other
tified to obtain specific activities. Values represent the mean ⫾ S.E.
residues at the active site is reflected
in the Km for substrate that is
increased ⬇10-fold relative to that
of the wild-type enzyme. Catalysis
by S245A is unaltered with respect
to Vmax, but this mutant has lower
affinity for HA as indicated by the
⬇3-fold higher Km (Fig. 3A and
Table 1). Thus, the importance of
Ser245 at the enzyme active site is to
ensure substrate binding. Collectively, these conserved residues are
important for maximal catalytic
efficiency, although they are not
essential for function.
Alteration of Arginine 265 Perturbs Active Site Architecture—Kinetic analysis of the R265L mutant
confirmed a significant reduction in
enzyme activity, as observed in the
microplate assay (Table 1). In fact,
FIGURE 3. Kinetic analysis of wild-type and mutant Hyal1 reveals the importance of active site residues in
substrate affinity as well as catalysis. Purified protein was incubated for 60 min with the indicated concen- this mutation was as disruptive as
trations of sodium hyaluronate (HA, 20 kDa) before quantification of cleavage events by Morgan-Elson color D129N, retaining only ⬇4% of wildreaction as described under “Experimental Procedures.” Data were fitted to an equation for single site associtype activity at 50 M HA (Table 1).
ation and used to calculate specific activities, Vmax and Michaelis constants as presented in Table 1. Mean ⫾ S.D.
of triplicate determinations for each HA concentration were plotted with the curve fit. Results for Hyal1 species However, dependence of activity on
that exhibited saturable kinetics in the conditions evaluated are shown: A, Hyal1 wild-type (WT) and S245A HA concentration was approxipoint mutant (0.5 g of enzyme assayed); C, Y202F and D129N (2.5 g of enzyme), plotted on a different scale
to illustrate saturability; B, E131Q, and D, Y247F had negligible activity at all HA concentrations (2.5 g of mately linear over the range tested
enzyme).
and did not approach saturation, so
Glutamate 131 and Tyrosine 247 Are Essential Catalytic
Residues—For kinetic analyses, we measured Hyal1 activity by
the method of Reissig et al. (36), in which cleavage events are
quantified by the reaction of liberated N-acetylglucosamine
ends with a colorimetric substrate. Activity of the wild-type
enzyme was saturable with increasing substrate concentration
(Fig. 3A). Apparent kinetic constants Km and Vmax were calculated by non-linear curve fitting of the data to an equation for
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we were unable to determine kinetic constants for this mutant.
At the maximum HA concentration of 125 M (2.5 mg/ml),
activity was 0.67 ⫾ 0.02 mol/min/mg, which was 7.3% of the
TABLE 1
Summary of Hyal1 wild-type (WT) and mutant kinetic constants
Enzyme

Km

Vmax

% WT activity
at 50 M HA

M

mol/min/mg

Hyal1 wild-type

38.1 ⫾ 4.8

12.5 ⫾ 0.7

Catalytic mutants
E131Q
Y247F
D129N

NAa
NA
181 ⫾ 19b

NA
NA
1.9 ⫾ 0.1b

0.08 ⫾ 0.01
0.04 ⫾ 0.01
5.10 ⫾ 0.09

Substrate binding mutants
Y202F
S245A

367 ⫾ 37b
110 ⫾ 19

6.7 ⫾ 0.5b
10.7 ⫾ 1.1

11.1 ⫾ 0.0
41.1 ⫾ 0.4

Putative structural mutants
R265L
N216A
N350A
N350tr
L356tr

NSc
103 ⫾ 14
NS
NS
NS

NS
10.0 ⫾ 0.8
NS
NS
NS

4.18 ⫾ 0.09
44.6 ⫾ 1.3
0.12 ⫾ 0.01
2.49 ⫾ 0.17d
6.29 ⫾ 1.50d

100.0 ⫾ 1.8

a

NA indicates no measurable activity at any HA concentration.
Indicates extrapolated value from saturable curve fit.
NS, not saturable, indicates data do not fit a saturation curve.
d
Values measured at 125 M HA.
b
c

wild-type enzyme activity at this amount. Thus, catalytic function was impaired within this range of HA concentrations, but it
was not possible to predict whether Vmax was altered.
Disulfide Stabilization Is Not Critical for Activity—The
Hyal1 enzyme contains five disulfide bonds, three of which are
located in a C-terminal EGF-like domain remote from the
enzyme active site. However, one disulfide bond occurs
between Cys207 and Cys221, both adjacent to the putative substrate binding groove. This disulfide appears to be required for
stabilization of a loop containing the Asn216 glycosylation site
(Fig. 1A). Disulfides have been suggested to have importance in
the function of PH-20 (38), but their role has not been tested
extensively. To test the significance of disulfides for activity of
Hyal1, we treated affinity purified protein with the disulfide
reducing agent DTT, and evaluated its resulting activity (Fig. 4).
Both conditioned media and FLAG-affinity purified Hyal1 contained abundant protein activity. Interestingly, this activity was
completely eliminated in a HA substrate gel assay (Fig. 4B),
whereas no effects were observed in the microplate format (Fig.
4C), unless the enzyme was first heat-inactivated. Kinetic analysis revealed identical saturation and Michaelis constants for
concentration dependence of specific activity (Fig. 4D), consistent with results of the microplate assay. Furthermore, saturation curves and kinetic constants were not affected at any concentration of DTT (1, 10, or 100 mM), nor by preincubation with
5 mM ␤-mercaptoethanol (data not shown). Thus, disulfides
probably affect folding of the enzyme and long term stability in
the acidic environment of the lysosome, but the folded Hyal1
active site does not intrinsically appear to require disulfide
bonds for its optimal conformation.
Deglycosylation of Hyal1 or Mutagenesis of Asparagine 350
Eliminates Activity—In studies of the PH-20 isozyme, deglycosylation was found to reduce hyaluronidase activity in substrate
gel assays (38). Three canonical N-glycosylation sites are present in Hyal1. To test their importance, N-glycosyl moieties
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FIGURE 4. Disulfide bonds are important for the stability but not the
activity of intact Hyal1. FLAG affinity purified Hyal1 (wild-type) was incubated in the absence or presence of 1 mM DTT prior to Western blotting (A),
HA substrate gel analysis (B), or quantification of activity by microplate assay
(C) and kinetic analysis (D), as described under “Experimental Procedures”.
Lanes in A contain: 1) Hyal1 conditioned media; 2) anti-FLAG affinity column
flow-through; and 3) eluted Hyal1. In B, lane 1 contains Hyal1 transfectantconditioned media; lanes 2 and 3 contain purified Hyal1 with and without 1
mM DTT, respectively. Data plotted are the mean ⫾ S.E. (C) and mean ⫾ S.D.
(D) of triplicate determinations. D, the concentration dependence of specific
activity was fitted to an equation for single site association. Curve fits are
superimposed as indicated for assays in the continuous absence or presence
of 1 mM DTT following the initial preincubation period. IB, immunoblot.

were digested from purified Hyal1 and activity was assayed relative to extent of glycosylation. Removal of glycosides was monitored concurrently by Western blot (Fig. 5A). Significant digestion of glycosides was already evident at 0 h as a shift in
molecular masses from a major ⬇52-kDa band in the untreated
sample, presumably corresponding to the fully glycosylated
species, to a series of 4 bands within the first 5 min after PNGase
F addition. Despite this apparent shift, the HA dependent activity curve at this time point was superimposable for untreated
and treated samples (Fig. 5A and data not shown). The 52-kDa
band was virtually absent by 2 h and no longer visible at 4 h,
replaced by a doublet of ⬇42 and ⬇45 kDa in the treated samples. Longer digestion times did not alter this pattern. Kinetic
analysis showed Hyal1 activity decreased in a time dependent
fashion with deglycosylation (Fig. 5A), with apparent Vmax values only 57, 12, and 1.3% of the untreated Vmax at 1, 2, and 4 h,
respectively.
To confirm the importance of the glycosyl moieties in Hyal1
catalytic function, we mutagenized two of the N-glycosylation
sites. One, Asn216, was located in the disulfide-positioned loop
that forms part of the extended active site, and the other,
Asn350, was located in the C-terminal EGF-like domain. Consistent with the non-essential role of disulfide loop positioning
in catalysis, the N216A mutant was maximally active in both the
microplate assay (Fig. 2B) and kinetic analysis (Fig. 5B),
although its Km for HA was increased ⬇3-fold. N-Glycosylation
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at position 216 was not required for expression or extracellular
secretion of the enzyme (Fig. 2A), but the N216A mutant was
observed as a doublet of ⬇52 and ⬇48 kDa in some preparations (Fig. 5B), suggesting variable glycosylation. In contrast,
the N350A mutant was expressed only in the soluble cell lysate
as a species of ⬇48 kDa. The wild-type protein was consistently
observed in both media and lysate as a 52-kDa band. Kinetic
analysis of the wild-type enzyme affinity purified from the
lysate produced activity curves identical to those of Hyal1
from conditioned media (data not shown), but the lysatepurified N350A mutant exhibited negligible activity at any
HA concentration tested (⬇0.1% of wild-type at 50 M,
Table 1 and Fig. 5B).
Deletion of the EGF-like Domain Abolishes Hyal1 Activity
Independently of Asparagine 350—The C-terminal EGF-like
domain is not found in the bacterial or bee venom hyaluronidases, so previous models of Hyal1 using coordinates for the bee
venom ortholog depicted this region as an independently
folded domain with minimal contacts to the active site containing domain. Inspection of the human Hyal1 model reveals a
single overall folded domain, with extensive contacts between
the EGF-like region, the sugar moieties of the Asn350 glycosyl
adduct housed within that region, and the remainder of the
protein. We introduced stop codons at position 350 (N350tr),
which deleted 86 amino acids, including the Asn350 glycosylation site, and at position 356 (L356tr), which deleted the 80amino acid EGF-like domain but retained Asn350. Neither deletion mutant was secreted to the extracellular space but both
were expressed well in the soluble lysate (Fig. 5C). Western
blot showed the N350tr lysates contained a major band of
⬇38 kDa, the predicted molecular mass for the polypeptide,
whereas the major band in L356tr lysates was ⬇42 kDa, consistent with the 4-kDa shift observed for the fully glycosylated wild-type enzyme. The lysates showed ⬇2.5 and ⬇6.3%
of wild-type activity for N350tr and L356tr, respectively, at
the 125 M HA amount. Thus, loss of this domain is deleterious to both secretion and activity of Hyal1, although the
residual activity suggests the effect is indirect.

DISCUSSION
Hyaluronidase enzymes, most extensively Hyal1, have been
implicated in normal and pathological extracellular matrix
turnover. Crystallographic studies have illuminated the Hyal1
structure (27) and investigation of the wild-type enzyme puri-

FIGURE 5. Glycosylation of asparagine 350 is essential for enzyme activity. A, purified Hyal1 (wild-type) was incubated in the absence or presence of
PNGase F for 0, 1, 2, or 4 h prior to analysis by Western blot probed with
anti-FLAG antibody (upper panel) and kinetic assay. Mean ⫾ S.D. and curves
fitted to a single site association are shown from triplicate determinations.
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B, site-specific mutations were made to eliminate two of the three N-glycosylation sites in Hyal1. Purified protein was compared with wild-type in Western
blots probed with anti-FLAG (upper panel). MW denotes the molecular weight
ladder; the band is 52 kDa. The N216A mutant was purified from the conditioned media and kinetic parameters determined exactly as for the wild-type
enzyme. The N350A mutant was expressed solubly but was not secreted, so it
was purified from the soluble HEK293 cell lysate and used in 5-fold excess for
kinetic assay. Mean ⫾ S.D. and curves fitted to a single site association are
shown from triplicate determinations. C, stop codons were introduced by
site-directed mutagenesis of the Hyal1 coding sequence, to generate C-terminal truncations that eliminated the EGF-like domain at (N350tr) or after
(L356tr) the Asn350 glycosylation site. Western analysis of soluble HEK293 cell
lysates from vector (NC), Hyal1 wild-type (WT), and two separate transfections
each of N350tr and L356tr are shown in the upper panel. Protein was purified
from each lysate and assayed for specific activity at a single HA concentration
(125 M, HA 20 kDa) using the Morgan-Elson color reaction. Activity of each is
plotted relative to that of wild-type Hyal1.
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fied from insect cells demonstrated its minimum octasaccharide substrate requirement (22). Several naturally occurring
inhibitors have been reported, but rational design of high affinity and/or mechanism-based inhibitors to control disease progression requires detailed characterization of Hyal1 chemistry.
In particular, specific molecular features conferring enzymatic
properties to Hyal1 have not been previously examined. In this
report, we confirmed the presumed catalytic roles of two active
site residues, identified three additional catalytic components,
and characterized several structurally stabilizing features,
including the intriguing EGF-like domain.
Typically, hyaluronidase activity has been measured at a single time point and HA concentration. This is useful for detection of small amounts of enzyme in complex mixtures. However, this activity represents a maximum saturation level and
cannot be used to compare quantitatively among hyaluronidases. To establish a system for detailed kinetic analysis, it was
first necessary to generate large scale expression and purification schemes. Active Hyal1 had been produced previously using
insect cell expression systems (22–24), but the sugar content of
glycosyl moieties is often not accurately reproduced by insects
relative to the human sequences. Because both PH-20 and
Hyal1 hyaluronidases have shown sensitivity to glycosylation,
the nature of these modifications has the potential to impact
enzymatic function. As an alternative, we expressed wild-type
and mutant human Hyal1 with a FLAG epitope tag and immunoaffinity purified the resulting protein from the conditioned
media of either human prostate carcinoma cells or embryonic
kidney cells. Michaelis-Menten kinetic values were not previously determined for Hyal1 but specific activity reported at a
given concentration (22, 24) is within an order of magnitude of
the values we report here. Using the octasaccharide substrate,
saturation was essentially observed within the same range we
utilized (22), adjusted for the 10-fold difference in molar mass
of the 2-kDa octasaccharide versus the 20-kDa polymeric HA
substrate. The somewhat lower activity of Hyal1 purified from
insect cells relative to the enzyme we have prepared from
human cell culture may be due either to differences in utilization of these substrate sizes or in glycosylation.
In studies of PH-20, the residual activity of the analogous
mutation to D129N, absent in E131Q, was interpreted in favor
of an essential direct role in chemical catalysis for Glu131, and a
supporting role in transition state stabilization for Asp129 (2,
25). It is clear that the acidic character of the residue is critical in
both cases. This observation is also consistent with the mechanism illustrated in Scheme 1, in which protonated Glu131 serves
as a general acid for proton transfer to the hydroxyl leaving
group upon glycosidic cleavage. The optimal pH of the enzyme
of ⬇4.0 is close to the pKa for the ␥-carboxylate of free glutamic
acid, which supports its ability to serve subsequently as a general base to deprotonate and activate incoming water for
hydrolysis. Glutamine lacks dissociable protons and is therefore incapable of substituting as a general acid/base. During
catalysis, the substrate acetamido group becomes polarized for
nucleophilic attack at the anomeric carbon, developing a positive charge on the amide nitrogen while forming the oxyanion
nucleophile. Asp129 must preserve its negative charge to facili-
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tate polarization by neutralizing the positive charge on the
nitrogen.
Tyr247 was also an essential residue in our analysis. Placement of Tyr247 in the structural model suggests its role is to
coordinate and stabilize the oxyanion during transition state
formation: the hydroxyl of Tyr247 is optimally located for
hydrogen bond donation to the carbonyl oxygen. An inert role
in binding is less likely, because the Y247F mutation preserves
the hydrophobic character of the residue that is thought to be
important for association with sugar rings in the substrate.
Structural inspection predicts Ser245 does not contact the substrate directly but that the side chain hydroxyl would be an
essential linchpin between Tyr202 and Tyr247, forming a hydrogen bond with the hydroxyl of Tyr202 and the pi cloud of Tyr247
and thereby positioning them both. This is consistent with the
comparable Vmax but reduced apparent substrate binding of
both the Y202F and S245A mutants.
The Arg265 guanidino forms a salt bridge with the side chain
carboxylate of Asp206 in the crystal structure of human Hyal1.
Interestingly, this interaction bridges two strands of “unstructured” coil that shape the active site of the enzyme. One of these
strands, containing Asp206, positions Tyr202 optimally for binding to the substrate during catalysis. The other strand orients
Ser245 and the essential Tyr247, exact placement of which is
critical for transition state formation. Thus, instead of implicating the arginine directly in substrate binding via salt bridging
with the carboxylate moieties, as was previously postulated for
an analogous mutation in PH-20, the R265L mutation in Hyal1
shows its importance for structural integrity. The magnitude of
its effect on catalysis also suggests the shape and rigidity of the
active site cavity is critical to its function, regardless of the presence of specific catalytic residues.
Despite the essential interaction of Asp206 with Arg265 in
active site architecture, a disulfide between Cys207 and Cys221,
which holds the coil strand containing Asp206 and Tyr202 in
contact with the next adjacent coiled strand to form a loop with
Asn216 at the apex, is apparently not required for Hyal1 activity.
This loop may be stabilized by other interactions and/or not
directly involved in substrate binding or catalysis. Furthermore,
because this loop is the most remote of the contiguous secondary backbone elements that form the active site crevice, it may
have the most structural and conformational fluidity. This
would be consistent with the relatively high mobility in the
structure of this region. It is interesting to find that disulfides in
general are only essential for hyaluronidase activity in substrate
gel assays. One major difference between this assay format and
the microplate or Morgan-Elson color reaction formats is that
the proteins are first denatured by SDS and immobilized in an
acrylamide matrix for the substrate gel, presumably limiting
their conformational mobility, whereas native, soluble protein is analyzed in the quantitative assays. This result suggests that disulfides assist the adoption of native folded
structure and are essential to the partial refolding that allows
hyaluronidase to function upon renaturation by removal of
SDS from the substrate gel. Because the native structure is
not disrupted in microplates, disulfides are not required for
short term folded structures and therefore appear irrelevant
to protein activity.
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Prior studies of Hyal1 and PH-20 revealed reduced activity in
solution and substrate gel assays, respectively, upon partial
enzymatic removal of N-glycosides (24, 38). However, complete
digestion was not achieved. The results reported here provide
the first direct temporal link between the kinetics of deglycosylation and the loss of hyaluronidase activity. In addition, this
analysis has shown definitively that Hyal1 lacks activity in the
absence of glycosylation, whether resulting from glycoside
removal post-purification or from expression as a point mutant
incapable of being glycosylated at a specific residue. We were
able to follow glycoside removal by changes in the molecular
mass of Hyal1 by Western blot, in which an apparent 52-kDa
band in untreated samples was presumed to be fully glycosylated, whereas a shift to two bands of ⬇42 and 45 kDa was
consistently the end product of PNGase treatment and likely is
fully deglycosylated. Two bands may indicate that one species
retains the 22-amino acid signal peptide and the other has had
it cleaved. The fourth band seen in significant quantity is an
intermediate species that appears in the N216A lysate and is the
identical size of the N350A mutant, thus this is probably deglycosylated only at position 350. Because the N350A mutant
completely lacked activity, deglycosylation at Asn350 is probably the most detrimental to activity.
Lysosomal enzymes are commonly glycosylated (39), presumably to protect the protein in the acidic environment of this
compartment, conditions under which Hyal1 is optimally
active. The region of Hyal1 that contains Asn350 is relatively
mobile as indicated by the crystallographic data, but extensive
contact between the sugar modifications and the secondary
structural elements may be important for maintaining stability
of the overall folded structure of the protein indirectly. The
possibility exists that glycosyl adducts could facilitate catalysis
directly by promoting association with the polymeric HA substrate and increasing affinity. However, the kinetic analysis
showed that activity of deglycosylated Hyal1 at all time points
was still saturable with increasing substrate concentration, but
that Vmax was reduced. If glycosylation state only affected affinity, maximal rate of catalysis would not be expected to change.
Asn350 was modeled in the structure with a hexasaccharide
adduct that was fitted to visible electron density, which further
supports its primary role in structural integrity relative to the
other glycosylation sites. No electron density was present for
Asn216 modification so either this residue is not modified or
high mobility in this region obscures additional atoms from
view. Support for Asn216 modification derives from the observation that the N216A mutant is partly secreted and active, but
intracellularly about 50% of the protein is a species that lacks
the ⬇4-kDa adduct, such that it is the same size as N350A on a
Western blot. Thus, glycosylation at position Asn216 may not be
extensive but may facilitate folding and maturation. The side
chain of Asn216 is modeled as oriented to the solvent accessible
surface of the enzyme, with no obvious requisite interactions,
but it may nonetheless interact with HA itself, which would
explain the difference in Km between wild-type and N216A
Hyal1. Asn99 is modeled with two sugar adducts. This highly
mobile region is directed outward and remote from the active
site and may be less structurally critical, perhaps lacking extensive contact within the main domain.
APRIL 3, 2009 • VOLUME 284 • NUMBER 14

It has been proposed that the C-terminal EGF-like domain,
found in several reported splice variants of Hyal1, may be the
site of as yet undefined protein-protein interactions (27). The
results presented here suggest that such interactions would
have to occur specifically with the solvent-exposed surface of
the domain, because the inactivity of the truncated mutants and
their inability to be secreted imply that this region does not
function as an independently folded domain. Its homology to
EGF may be a coincidental folding motif. However, numerous
extracellular matrix proteins, such as laminin, that bear similar
domains have been shown to activate EGF-type signaling
although they do not compete directly with EGF for cell surface
binding (35).
The analysis of Hyal1 point mutants highlights the importance of specific conserved residues in catalytic function, but
also identifies active site conformation as a critical factor. Disrupted activity resulted from the R265L mutation but not from
N216A or global disulfide reduction. Because each of these perturbations has the potential to impact structural integrity of the
enzyme and each is located in positions of potential direct contact with bound substrates, the differences suggest areas of
lesser or greater mobility within the protein may be important
for the accommodation of diverse HA substrate sizes. Inspection of the Hyal1 solvent-accessible surface according to its
crystal mobility reveals an N-terminal domain encompassing
residues from Pro62 to Pro205 that displays higher collective
structural mobility. This suggests that the N-terminal portion
may move as an entity relative to the remainder of the protein,
like a closing finger and thumb. The thumb appears to be the
similarly mobile loop containing Asn216. Together the closing
appendages may regulate clasping of polymeric HA substrates
and release of cleaved products. In contrast, residues in the
active site groove, and the hydrophobic folded core of the protein, exhibit the least mobility. At least two residues partially
obscure the substrate solvent accessibility and are among the
residues with the least motion. One of these is a tryptophan
(residue 321) that makes van der Waals contact with the bound
carbon rings and the other is Tyr247, which interacts with the
acetamide of the newly cleaved substrate. This is consistent
with a well defined active site conformation that constrains the
bound ligand for catalysis, whereas the mobile regions allow
promiscuity in polymeric length of the substrate.
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Supplementary figure 1. Intrinsic tryptophan fluorescence of native and denatured Hyal1.
Purified Hyal1 wild-type (WT) and each of the inactive point mutants was evaluated for
structural integrity by fluorescence scanning following tryptophan excitation at 295 nm. Spectra
were collected on 50 nM protein in a buffer of 50 mM tris-HCl, pH 7.0, and 150 mM NaCl in the
absence (native) or presence (denatured) of 3M guanidine-HCl as indicated. All spectra were
recorded following a 3 min incubation at room temperature.

Supplemental Table 1. Primer sequences for Hyal1 site-directed mutagenesis
Primer Label
Primer Sequence
Hy1wt Forward

TGACAAGCTTTTTAGGGGCCCCTTGC

Hy1wt Reverse

CTGAGAATTCTCACCACATGCTCTTC

D129N Forward

GGGCTGGCAGTCATCAACTGGGAGGCATGGC

D129N Reverse

GCCATGCCTCCCAGTTGATGACTGCCAGCCC

E131Q Forward

GCAGTCATCGACTGGCAGGCATGGCGCCCAC

E131Q Reverse

GTGGGCGCCATGCCTGCCAGTCGATGACTGC

Y202F Forward

GGCCTCTGGGGCTTCTTTGGCTTCCCTGACT

Y202F Reverse

AGTCAGGGAAGCCAAAGAAGCCCCAGAGGCC

S245A Forward

CGTGCCCTCTATCCCGCCATCTACATGCCCG

S245A Reverse

CGGGCATGTAGATGGCGGGATAGAGGGCACG

Y247F Forward

CTCTATCCCAGCATCTTCATGCCCGCAGTGC

Y247F Reverse

GCACTGCGGGCATGAAGATGCTGGGATAGAG

R265L Forward

ATGTATGTGCAACACCTTGTGGCCGAGGCAT

R265L Reverse

ATGCCTCGGCCACAAGGTGTTGCACATACAT

N216A Forward

CTATGACTTTCTAGGCCCCGCCTACACCGGCCAGTGC

N216A Reverse

GCACTGGCCGGTGTAGGCGGGGCCTAGAAAGTCATAG

N350A Forward

TACACTGGGGCCCTTCATCCTGGCCGTGACCAGTGGGGC

N350A Reverse

GCCCCACTGGTCACGGCCAGGATGAAGGGCCCCAGTGTA

N350tr Forward

GGGCCCTTCATCCTGTAGGTGACCAGTGGGGCC

N350tr Reverse

GGCCCCACTGGTCACCTACAGGATGAAGGGCCC

L356tr Forward

GTGACCAGTGGGGCCTGACTCTGCAGTCAAGCC

L356tr Reverse

GGCTTGACTGCAGAGTCAGGCCCCACTGGTCAC
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